WARRANT AGENT AGREEMENTWarrant Agent Agreement • September 23rd, 2022 • Bone Biologics Corp • Orthopedic, prosthetic & surgical appliances & supplies • New York
This Warrant Agent Agreement (this “Warrant Agreement”), dated as of [__], 2022 (the “Issuance Date”) between Bone Biologics Corp., a company incorporated under the laws of the State of Delaware (the “Company”), and Equiniti Trust Company, a limited trust company organized under the laws of the State of New York (the “Warrant Agent”).
BONE BIOLOGICS CORPORATION UNDERWRITING AGREEMENT [ ]Units Consisting of [ ] Shares of Common Stock, AndUnderwriting Agreement • September 23rd, 2022 • Bone Biologics Corp • Orthopedic, prosthetic & surgical appliances & supplies • New York
BONE BIOLOGICS CORPORATION, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital, LLC is acting as Representative (the “Representative”), an aggregate of [ ] Units (the “Firm Units”), each Firm Unit consisting of: (i) one share of the Company’s common stock, $0.001 par value per share (the “Common Stock”); (ii) one Series A warrant to purchase one share of Common Stock (the “Series A Warrants” and each a “Series A Warrant”); (iii) one Series B warrant to purchase one share of Common Stock (the “Series B Warrants” and each a “Series B Warrant”); and (iv) one Series C warrant to purchase one share of Common Stock (the “Series C Warrants” and each a “Series C Warrant” and together with Series A Warrants and Series B Warrants, the Purchase Warrants). The [ ] shares of Common Stock referred to in this S
